Data Presented at ACC 2013 Confirms Use of Corus@ CAD in Women with Suspected Obstructive Coronary Artery Disease Influences Patient Management Decisions
March 11, 2013 8:31 am | by The Associated Press | News | CommentsCardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a prospective study that evaluated how Corus@ CAD, a blood-based gene expression test, influenced cardiologists' patient management decisions in women with suspected obstructive coronary...
NovaSom is AASM’s First Approved Out of Center Sleep Test Provider
March 11, 2013 8:04 am | by The Associated Press | News | CommentsGLEN BURNIE, Md.--(BUSINESS WIRE)--Mar 11, 2013--NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announced it has been recognized by the American Academy of Sleep Medicine (AASM) as the first Approved Out of Center Sleep...
American Academy of Private Physicians (AAPP) Selects Itamar-Medical’s EndoPAT™ and WatchPAT™ Products to Promote Patient Wellness
March 11, 2013 8:00 am | by The Associated Press | News | CommentsCAESAREA, Israel--(BUSINESS WIRE)--Mar 11, 2013--Itamar-Medical (TASE: ITMR), the world's leader of noninvasive technology for diagnosis of cardiovascular health, announced today that it has an agreement with the American Academy of Private Physicians (AAPP) to include Itamar's EndoPAT &...
DNA Sequencing Giant Illumina Joins Hunt for Autism Blood Test
March 8, 2013 4:37 pm | by Massachusetts Institute of Technology | News | CommentsIllumina will work with SynapDx’s to find a blood-test that could allow treatment to start earlier. Massachusetts startup SynapDx announced on Wednesday that it will work with DNA sequencer manufacturer Illumina to develop early detection tools for autism spectrum disorders, according to a release.
Endeavor Power Corporation Introduces Its Proprietary FDA Cleared Target System Platform Technology
March 8, 2013 8:00 am | by PR Newswire | News | CommentsCAMBRIDGE, Mass., March 8, 2013 /PRNewswire/ -- Endeavor Power Corporation ("Endeavor Power" or the "Company") (OTCQB: EDVP) introduces its proprietary FDA Cleared Target System Platform Immunoassay Testing Technology ("Target System"). Endeavor Sciences, Inc. ("Endeavor"), the...
Philips Healthcare and Infraredx Introduce Solution to Enable Seamless Integration of TVC Imaging System with Philips’ Allura Xper Systems
March 7, 2013 8:30 am | by The Associated Press | News | CommentsANDOVER, Mass. & BURLINGTON, Mass.--(BUSINESS WIRE)--Mar 7, 2013--Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced the availability...
In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
March 7, 2013 8:04 am | by PR Newswire | News | CommentsGlobal in vitro diagnostics markets are a bright spot in the healthcare industry largely due to the increasing focus on global expansion. This is particularly seen in emerging markets that continue to gain steam as markets flatten. This briefing, featuring a live Q&A with the industry analyst, will explore the IVD market dynamics in these and other key regions globally.
Clinical Trial Results for Dune Medical Devices' MarginProbe@ System Presented at 66th Annual SSO Cancer Symposium
March 7, 2013 8:01 am | by The Associated Press | News | CommentsDune Medical Devices, Inc., announced today that results from the pivotal clinical trial for the MarginProbe System, Dune's breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, were presented at the 66th Annual Society of Surgical Oncology (SSO) Cancer ...
HD Medical, Inc. Launches US Business Operations
March 6, 2013 8:05 am | by The Associated Press | News | CommentsSAN FRANCISCO--(BUSINESS WIRE)--Mar 6, 2013--At ACC.13, HD Medical Inc. a recently formed medical device research and development innovator headquartered in Santa Clara, CA, today announces the launch of US business operations. This new company is delivering revolutionary diagnostic technologies...
Appointment of Dr. Ian Gilham as Chairman of the Board
March 5, 2013 2:23 pm | by Bio-Medicine.Org | News | CommentsLISBON, Portugal , March 5, 2013 /- Biosurfit, a rapidly-growing company focused on the Point of Care medical diagnostic market, is pleased to announce today the appointment of Dr. Ian Gilham as Chairman of the Board. Previously, Dr. Ian Gilham was Chief Executive Officer of Axis-Shield plc, the in-vitro diagnostics company acquired by Alere in November 2011 for £...
AgPlus Diagnostics Unveils First Working Prototype of Handheld, Rapid, On-the-Spot Diagnostic System
March 5, 2013 12:01 pm | by AgPlus Diagnostics | News | CommentsAgPlus Diagnostics is pleased to announce that the first functional prototype of the handheld AgPlus Diagnostics analytical platform is now fully operational and available for demonstration. Delivering laboratory-grade, quantifiable results within just 10 minutes of sample application, the portable AgPlus technology system has enormous potential in a wide variety of applications.
Welch Allyn Will Showcase the EarlySense Contact-Free Patient Monitoring and Electronic Vitals Documentation Systems at HIMSS13
March 4, 2013 10:24 am | by Welch Allyn | News | CommentsWelch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, will showcase the EarlySense Vitals Surveillance System at the Healthcare Information and Management Systems Society (HIMSS) trade show this week at the Ernest N. Morial Convention Center in New Orleans.
FDA Clears Philips' MicroDose SI Mammography System
March 4, 2013 9:29 am | by Mass Device | News | CommentsTechnology giant Philips won FDA clearance for its MicroDose SI full-field mammography system, which the company hopes to leverage as a platform new mammogram imaging applications. The system promises reduced radiation dosages in producing high quality images, 5-minute exam times and ergonomic design with curved and warmed breast support.
Larry Cohen Appointed CEO of Exalenz Bioscience
March 4, 2013 8:30 am | by The Associated Press | News | CommentsMODIIN, Israel--(BUSINESS WIRE)--Mar 4, 2013--Exalenz Bioscience (TASE: EXEN), a developer of a unique medical device intended for the diagnostics and management of disease of the digestive tract and the liver, has reported today the appointment of Larry Cohen as the company's CEO.
Virtua and Alere Form Alliance for Care Coordination
March 4, 2013 8:01 am | by The Associated Press | News | CommentsVirtua, a healthcare delivery leader in southern New Jersey, and Alere Inc. (NYSE: ALR), a global leader in health information solutions, announced today a strategic alliance to provide health information systems and home-based, biometric monitoring devices to support care coordination ...
Doctors Can Detect Skin Cancer Earlier With New Modernizing Medicine and 3Gen, Inc. Partnership
March 1, 2013 9:03 am | by The Associated Press | News | CommentsModernizing Medicine, the creator of the Electronic Medical Assistant (EMA), a cloud-based specialty-specific electronic medical records (EMR) system, announced today that it has partnered with 3Gen, Inc., a product design and development company which...
Santech, Inc. joins Qualcomm Life’s 2net Ecosystem
March 1, 2013 9:00 am | by The Associated Press | News | CommentsSAN DIEGO--(BUSINESS WIRE)--Mar 1, 2013--Santech, Inc. has integrated its mobile messaging platform, SanText®, to the 2net ™ Platform and Hub, designed with attention to HIPAA privacy and security requirements, and leveraging the cloud-based platform for biometric sensor data operated by Qualcomm...
OPKO Point-of-Care Technology Demonstrated on Mobile Device with Cloud Connectivity to Diagnose and Track Disease in Africa
March 1, 2013 8:16 am | by The Associated Press | News | CommentsMIAMI--(BUSINESS WIRE)--Mar 1, 2013--OPKO Health, Inc. (NYSE: OPK) announced that a study published online in Clinical Chemistry, and to be included in the April 2013 print issue, describes the application of OPKO’s point-of-care system to mobile diagnostics, a major advance towards providing...
Philips Receives FDA Clearance to Market MicroDose SI Mammography System
February 28, 2013 2:39 pm | by Bio-Medicine.Org | News | CommentsANDOVER, Mass. , Feb. 28, 2013 /- Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announces 510(k) clearance from the Food and Drug Administration (FDA) for its MicroDose SI system, the first full-field digital mammography (FFDM) system on the market with the capability to enable future Single-Shot Spectral Imaging applications*.
ChartMaxx@ and Appian Announce Partnership to Bring Next Generation Business Process Management to the Healthcare Industry at HIMSS13
February 28, 2013 1:08 pm | by The Associated Press | News | CommentsIn line with its reputation for being on the forefront of tools that provide insights for better healthcare, Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced a partnership between ChartMaxx@, its leading Document Management and...
Neuro Kinetics Adds Software, Engineering Professionals as Push Continues for Improved Testing of Battlefield Concussions
February 28, 2013 9:48 am | by The Associated Press | News | CommentsMedical diagnostic device manufacturer Neuro Kinetics, Inc. said today that it has added five software and engineering professionals to its staff as the company continues to develop new testing protocols for diagnosis of concussions and other brain injuries. ...
MEMS devices proliferate in the medical market
February 28, 2013 9:48 am | by Digi-Key Corporation | News | CommentsAs the utilization of MEMS continues to grow across various industry sectors, commercial successes like the use of STMicroelectronics’ PCR chips in drug delivery; Boehringer Ingelheim’s success with MEMS-based inhalers; and the microfluidic chips used in Abbott’s blood gas analyzers are helping to drive a growing demand for MEMS devices in the medical market.
T2 Biosystems Announces Patent Covering In Vivo Application of Direct Detection Technology
February 28, 2013 9:00 am | by The Associated Press | News | CommentsLEXINGTON, Mass.--(BUSINESS WIRE)--Feb 28, 2013--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued patent 8,368,402 (the ‘402 patent), “NMR systems for in vivo detection of analytes”.
Cognoptix begins pre-pivotal clinical trial of its drug/device test designed to identify Alzheimer’s disease via beta amyloid signature in the eyes
February 28, 2013 8:30 am | by The Associated Press | News | CommentsACTON, Mass.--(BUSINESS WIRE)--Feb 28, 2013--Cognoptix announced today that it has begun a 40-patient clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer’s disease patients via a beta amyloid (“Ab”) signature in their eyes. By detecting a specific fluorescent signature of...
NanoString Expands Leadership Team With the Hiring of Two Seasoned Executives
February 28, 2013 7:30 am | by The Associated Press | News | CommentsSEATTLE--(BUSINESS WIRE)--Feb 28, 2013--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Gary S. Riordan as Vice President of Quality and Regulatory Affairs and Kathy...


